世界の良性前立腺肥大症(BPH)治療装置市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)

GlobalInfoResearchが発行した調査報告書(GIR20SP11137)
◆英語タイトル:Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20SP11137
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年9月25日(※2024年版があります。お問い合わせください。)
◆ページ数:130
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療、製薬、バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、良性前立腺肥大症(BPH)治療装置の世界市場を広く調査・分析し、今後の市場展望をまとめております。良性前立腺肥大症(BPH)治療装置の種類別市場規模(外科治療、低侵襲治療、レーザー治療、その他)、用途別市場規模(不妊クリニック、病院、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Advin Urology、JenaSurgical GmbH、CONMED、Biolitec、HistoSonics, Inc.、Boston Scientific Corporation、LISA Laser Products GmbH、CoreTherm Medical, Inc. (ProstaLund)、Convergent Laser Technologies、KARL STORZ、Siemens、NeoTract、Lumenis Ltd.、Baxter International、Olympus、Medtronic、Medifocus, Inc.、Urotech、Urologix、Endo International
・地域別グローバル市場分析 2015年-2020年
・良性前立腺肥大症(BPH)治療装置の北米市場(アメリカ、カナダ、メキシコ)
・良性前立腺肥大症(BPH)治療装置のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・良性前立腺肥大症(BPH)治療装置のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・良性前立腺肥大症(BPH)治療装置の南米市場(ブラジル、アルゼンチン)
・良性前立腺肥大症(BPH)治療装置の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:外科治療、低侵襲治療、レーザー治療、その他
・用途別分析:不妊クリニック、病院、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論
【レポートの概要】

Market Overview
The Benign Prostatic Hyperplasia (BPH) Treatment Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global Benign Prostatic Hyperplasia (BPH) Treatment Devices sales will be xx in 2020 from Benign Prostatic Hyperplasia (BPH) Treatment Devices million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Benign Prostatic Hyperplasia (BPH) Treatment Devices market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the Benign Prostatic Hyperplasia (BPH) Treatment Devices industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Benign Prostatic Hyperplasia (BPH) Treatment Devices and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation
Benign Prostatic Hyperplasia (BPH) Treatment Devices market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Benign Prostatic Hyperplasia (BPH) Treatment Devices market has been segmented into
Surgical Treatment
Minimally Invasive Treatment
Laser Treatment
Other

By Application, Benign Prostatic Hyperplasia (BPH) Treatment Devices has been segmented into:
Fertility Clinics
Hospitals
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Benign Prostatic Hyperplasia (BPH) Treatment Devices market presented in the report. This section sheds light on the sales growth of different regional and country-level Benign Prostatic Hyperplasia (BPH) Treatment Devices markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Benign Prostatic Hyperplasia (BPH) Treatment Devices market.

The report offers in-depth assessment of the growth and other aspects of the Benign Prostatic Hyperplasia (BPH) Treatment Devices market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share Analysis
Benign Prostatic Hyperplasia (BPH) Treatment Devices competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Benign Prostatic Hyperplasia (BPH) Treatment Devices sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Benign Prostatic Hyperplasia (BPH) Treatment Devices sales, revenue and market share for each player covered in this report.

The major players covered in Benign Prostatic Hyperplasia (BPH) Treatment Devices are:
Advin Urology
JenaSurgical GmbH
CONMED
Biolitec
HistoSonics, Inc.
Boston Scientific Corporation
LISA Laser Products GmbH
CoreTherm Medical, Inc. (ProstaLund)
Convergent Laser Technologies
KARL STORZ
Siemens
NeoTract
Lumenis Ltd.
Baxter International
Olympus
Medtronic
Medifocus, Inc.
Urotech
Urologix
Endo International

Among other players domestic and global, Benign Prostatic Hyperplasia (BPH) Treatment Devices market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Benign Prostatic Hyperplasia (BPH) Treatment Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Benign Prostatic Hyperplasia (BPH) Treatment Devices, with price, sales, revenue and global market share of Benign Prostatic Hyperplasia (BPH) Treatment Devices in 2018 and 2019.
Chapter 3, the Benign Prostatic Hyperplasia (BPH) Treatment Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Benign Prostatic Hyperplasia (BPH) Treatment Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Benign Prostatic Hyperplasia (BPH) Treatment Devices market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Benign Prostatic Hyperplasia (BPH) Treatment Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

1 Market Overview
1.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Surgical Treatment
1.2.3 Minimally Invasive Treatment
1.2.4 Laser Treatment
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Fertility Clinics
1.3.3 Hospitals
1.3.4 Others
1.4 Overview of Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market
1.4.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Benign Prostatic Hyperplasia (BPH) Treatment Devices Industry Impact
1.6.1 COVID-19 Potential Implications for the Benign Prostatic Hyperplasia (BPH) Treatment Devices
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Benign Prostatic Hyperplasia (BPH) Treatment Devices
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 Advin Urology
2.1.1 Advin Urology Details
2.1.2 Advin Urology Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Advin Urology SWOT Analysis
2.1.4 Advin Urology Product and Services
2.1.5 Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 JenaSurgical GmbH
2.2.1 JenaSurgical GmbH Details
2.2.2 JenaSurgical GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 JenaSurgical GmbH SWOT Analysis
2.2.4 JenaSurgical GmbH Product and Services
2.2.5 JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 CONMED
2.3.1 CONMED Details
2.3.2 CONMED Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 CONMED SWOT Analysis
2.3.4 CONMED Product and Services
2.3.5 CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Biolitec
2.4.1 Biolitec Details
2.4.2 Biolitec Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Biolitec SWOT Analysis
2.4.4 Biolitec Product and Services
2.4.5 Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 HistoSonics, Inc.
2.5.1 HistoSonics, Inc. Details
2.5.2 HistoSonics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 HistoSonics, Inc. SWOT Analysis
2.5.4 HistoSonics, Inc. Product and Services
2.5.5 HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Boston Scientific Corporation
2.6.1 Boston Scientific Corporation Details
2.6.2 Boston Scientific Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Boston Scientific Corporation SWOT Analysis
2.6.4 Boston Scientific Corporation Product and Services
2.6.5 Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 LISA Laser Products GmbH
2.7.1 LISA Laser Products GmbH Details
2.7.2 LISA Laser Products GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 LISA Laser Products GmbH SWOT Analysis
2.7.4 LISA Laser Products GmbH Product and Services
2.7.5 LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 CoreTherm Medical, Inc. (ProstaLund)
2.8.1 CoreTherm Medical, Inc. (ProstaLund) Details
2.8.2 CoreTherm Medical, Inc. (ProstaLund) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 CoreTherm Medical, Inc. (ProstaLund) SWOT Analysis
2.8.4 CoreTherm Medical, Inc. (ProstaLund) Product and Services
2.8.5 CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Convergent Laser Technologies
2.9.1 Convergent Laser Technologies Details
2.9.2 Convergent Laser Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Convergent Laser Technologies SWOT Analysis
2.9.4 Convergent Laser Technologies Product and Services
2.9.5 Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 KARL STORZ
2.10.1 KARL STORZ Details
2.10.2 KARL STORZ Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 KARL STORZ SWOT Analysis
2.10.4 KARL STORZ Product and Services
2.10.5 KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Siemens
2.11.1 Siemens Details
2.11.2 Siemens Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Siemens SWOT Analysis
2.11.4 Siemens Product and Services
2.11.5 Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 NeoTract
2.12.1 NeoTract Details
2.12.2 NeoTract Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 NeoTract SWOT Analysis
2.12.4 NeoTract Product and Services
2.12.5 NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Lumenis Ltd.
2.13.1 Lumenis Ltd. Details
2.13.2 Lumenis Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Lumenis Ltd. SWOT Analysis
2.13.4 Lumenis Ltd. Product and Services
2.13.5 Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Baxter International
2.14.1 Baxter International Details
2.14.2 Baxter International Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Baxter International SWOT Analysis
2.14.4 Baxter International Product and Services
2.14.5 Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Olympus
2.15.1 Olympus Details
2.15.2 Olympus Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Olympus SWOT Analysis
2.15.4 Olympus Product and Services
2.15.5 Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Medtronic
2.16.1 Medtronic Details
2.16.2 Medtronic Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Medtronic SWOT Analysis
2.16.4 Medtronic Product and Services
2.16.5 Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Medifocus, Inc.
2.17.1 Medifocus, Inc. Details
2.17.2 Medifocus, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Medifocus, Inc. SWOT Analysis
2.17.4 Medifocus, Inc. Product and Services
2.17.5 Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Urotech
2.18.1 Urotech Details
2.18.2 Urotech Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Urotech SWOT Analysis
2.18.4 Urotech Product and Services
2.18.5 Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Urologix
2.19.1 Urologix Details
2.19.2 Urologix Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Urologix SWOT Analysis
2.19.4 Urologix Product and Services
2.19.5 Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.20 Endo International
2.20.1 Endo International Details
2.20.2 Endo International Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Endo International SWOT Analysis
2.20.4 Endo International Product and Services
2.20.5 Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturer Market Share in 2019
3.3.2 Top 6 Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Market Share by Regions
4.1.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Regions (2015-2020)
4.1.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Market Share by Regions (2015-2020)
4.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
4.3 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
4.5 South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Market Share by Country
5.1.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Country (2015-2020)
5.1.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Market Share by Country (2015-2020)
5.2 United States Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
5.3 Canada Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
5.4 Mexico Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Market Share by Country
6.1.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Country (2015-2020)
6.1.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Market Share by Country (2015-2020)
6.2 Germany Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
6.3 UK Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
6.4 France Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
6.5 Russia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
6.6 Italy Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Market Share by Regions (2015-2020)
7.2 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
7.3 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
7.4 Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
7.5 India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
7.7 Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Market Share by Country
8.1.1 South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Country (2015-2020)
8.1.2 South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Market Share by Country (2015-2020)
8.2 Brazil Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
8.3 Argentina Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
9.3 Turkey Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
9.4 Egypt Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
9.5 South Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Type (2015-2020)
10.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Market Share by Type (2015-2020)
10.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Type (2015-2020)
11 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Segment by Application
11.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2015-2020)
11.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Application (2015-2020)
11.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Application (2015-2020)
12 Market Forecast
12.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Growth Rate (2021-2025)
12.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast by Regions (2021-2025)
12.2.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast (2021-2025)
12.2.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast (2021-2025)
12.2.3 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast (2021-2025)
12.2.4 South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast (2021-2025)
12.2.5 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast (2021-2025)
12.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast by Type (2021-2025)
12.3.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Type (2021-2025)
12.3.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share Forecast by Type (2021-2025)
12.4 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast by Application (2021-2025)
12.4.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Application (2021-2025)
12.4.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

...

【掲載企業】

Advin Urology、JenaSurgical GmbH、CONMED、Biolitec、HistoSonics, Inc.、Boston Scientific Corporation、LISA Laser Products GmbH、CoreTherm Medical, Inc. (ProstaLund)、Convergent Laser Technologies、KARL STORZ、Siemens、NeoTract、Lumenis Ltd.、Baxter International、Olympus、Medtronic、Medifocus, Inc.、Urotech、Urologix、Endo International

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の良性前立腺肥大症(BPH)治療装置市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)(Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。